baber/WOPTO huggingface dataset:
Patent AU-2013357861-B2 (AU)
Title: Device and method for monitoring an extracorporeal blood circulation for detection of air bubbles
Inventor: GAGEL ALFRED
IPC: A61M1/36
Filed: 2013-11-19
Granted: 2018-05-10
Abstract: The invention relates to a device for monitoring an extracorporeal blood circulation of an extracorporeal blood treatment device for detecting air bubbles in the blood which is conveyed in the extracorporeal circulation by a blood pump. Moreover the invention relates to a method for monitoring an extracorporeal blood circulation for detecting air bubbles and to a device for extracorporeal blood treatment using a device for monitoring the extracorporeal blood circulation. The device according to the invention and the method according to the invention are based on monitoring the negative pressure in the extracorporeal blood circulation upstream of the blood pump, in order to be able to distinguish between the formation of microbubbles which are attributable to cavitation and an inclusion of air which is not caused by cavitation. If the negative pressure is above a predetermined limiting value and microbubbles are detected in the extracorporeal blood circulation, it is concluded that the microbubbles are generated by cavitation and the mechanisms for dissolving the microbubbles are not sufficient in order to remove the microbubbles again before they can enter the patient.
Patent AU-2013389570-B2 (AU)
Title: Stacking-type header, heat exchanger, and air-conditioning apparatus
Inventor: OKAZAKI TAKASHI
IPC: F28F9/02
Filed: 2013-05-15
Granted: 2016-04-07
Abstract: This laminated header (2) is provided with a first plate-like body (11) wherein a plurality of first outlet flow passages (11A) and a plurality of first inlet flow passages (11B) are formed, and a second plate-like body (12) that is laminated on the first plate-like body (11), and wherein at least part of a distribution flow passage, wherein a refrigerant that flows in from a second inlet flow passage flows out after being distributed to the plurality of first outlet flow passages (11A), and at least part of a confluence flow passage, wherein refrigerant that flows in from the plurality of first flow passages (11B) merges and flows out to a second outlet flow passage, are formed. The first plate-like body (11) or the second plate-like body (12) has at least one plate-like member wherein a flow passage through which refrigerant that flows into the first inlet flow passages (11B) flows, and a flow passage through which refrigerant that flows into the second inlet flow passage flows, are formed. A through section or recess is formed in at least a portion of the plate-like member between the flow passage through which refrigerant that flows into the first inlet flow passages (11B) flows, and the flow passage through which refrigerant that flows into the second inlet flow passage flows.
Patent AU-2013392520-B2 (AU)
Title: Bactericidal composition with synergistic effect
Inventor: ZHONG HANGEN
IPC: A01N43/80
Filed: 2013-07-09
Granted: 2017-04-27
Abstract: The present invention provides a bactericidal composition with synergistic effect. The composition contains two active ingredients A and B. The active ingredient A is benziothiazolinone. The active ingredient B is one of benthiavalicarb isopropyl, zoxamide, prothioconazole, boscalid, imidazole cycloheximide, fluopicolide, famoxadone, pyraclostrobin, picoxystrobin or fluazinam. The weight ratio of the two ingredients is (1:50) to (50:1). As shown in an experimental result, the bactericidal composition provided in the present invention has obvious synergistic effect, needs a small dosage, and needs lower cost, and is capable of effectively preventing and treating certain special fungal diseases of crops such as grains, vegetables and fruits, thereby expanding the sterilization spectrum, delaying the fungal resistance and improving the prevention and treatment effect.
Patent AU-2014202535-B2 (AU)
Title: The use of amisulpride as an anti-emetic
Inventor: GILBERT JULIAN CLIVE
IPC: A61K31/4178
Filed: 2014-05-09
Granted: 2016-05-26
Abstract: Amisulpride is used in the therapy of nausea, vomiting or retches. The therapy may utilise a novel injectable formulation, in unit dosage form, comprising less than 50 mg amisulpride.
Patent AU-2014209881-B2 (AU)
Title: Method for producing spray powders containing chromium nitride
Inventor: GRIES BENNO
IPC: C23C4/12
Filed: 2014-01-23
Granted: 2018-07-05
Abstract: The present invention relates to a method for producing sintered spray powders containing chromium nitride, comprising the following steps: a) preparing a powder mixture (A) comprising i) a powder (B) containing one or more components selected from the group consisting of Cr, CrN and Cr
Patent AU-2014214841-B2 (AU)
Title: Radiopaque polymers for medical devices
Inventor: GOODRICH STEPHEN D
IPC: A61K49/04
Filed: 2014-02-07
Granted: 2018-02-22
Abstract: Radiopaque polymer compositions and methods for making the compositions are provided. These radiopaque polymer compositions include polymer compositions comprising a crosslinked polymer network, the network comprising a first repeating unit derived from a monofunctional monomer and a second repeating unit derived from a multifunctional non-iodinated monomer wherein neither of the two monomers is fluorinated. Devices formed from radiopaque polymer compositions are also provided.
Patent AU-2014224579-B2 (AU)
Title: Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
Inventor: CZECHTIZKY WERNGARD
IPC: C07D417/14
Filed: 2014-03-07
Granted: 2018-05-10
Abstract: The present invention relates to substituted chroman-6-yloxy-cycloalkanes of the formula (I) in which Ar, R1 to R4, p and q are as defined in the claims. The compounds of the formula (I) are inhibitors of the sodium-calcium exchanger (NCX), especially of the sodium-calcium exchanger of subtype 1 (NCX1), and are suitable for the treatment of diverse disorders in which intracellular calcium homeostasis is disturbed, such as arrhythmias, heart failure and stroke. The invention furthermore relates to processes for the preparation of the compounds of the formula (I), their use as pharmaceuticals, and pharmaceutical compositions comprising them.
Patent AU-2014225705-B2 (AU)
Title: Microanchor
Inventor: LUNN RICHARD M
IPC: A61B17/04
Filed: 2014-03-06
Granted: 2018-08-30
Abstract: Examples of a suture anchor (100) having a small diameter and having a soft suture bridge (110) or suture eyelet (155) are described herein. The soft suture bridge/suture eyelet allows a repair suture to slide, which is desirable when tying knots. In some cases, the soft suture bridge/suture eyelet itself is made from a length of suture.
Patent AU-2014234335-B2 (AU)
Title: Apparatus for receiving a syringe into a fluid-dispensing apparatus, method therefor, and use of such a receptacle
Inventor: FAULHABER THOMAS
IPC: A61M5/145
Filed: 2014-03-19
Granted: 2018-07-05
Abstract: The invention relates to an apparatus (18) and a method for receiving a syringe into a fluid-dispensing apparatus (21) in a play-free manner, said apparatus comprising at least two clamping elements (3"), which can be resiliently preloaded and which grip the plunger flange of a syringe, wherein an elongated hole is provided for each clamping element (3"), in which elongated hole the clamping element slides and thus performs a rotational motion and a translational motion simultaneously during the gripping process. The invention further relates to a method therefor and a device having such an apparatus.
Patent AU-2014237492-B2 (AU)
Title: Infusion system with dual-chambered reservoir
Inventor: DAVIS LISA
IPC: A61M5/142
Filed: 2014-03-10
Granted: 2018-04-12
Abstract: Described herein are medical fluid infusion systems for pumping a fluid to a patient, such as in a hospital environment. In one aspect, disclosed is an infusion system including a drive assembly having a drive fluid reservoir and a drive mechanism configured to apply a force to drive fluid from the drive fluid reservoir through a length of tubing. The infusion system includes a hydraulic assembly having a first fluid chamber having an inlet port configured to be in fluid communication with the length of tubing and a second fluid chamber having an outlet port configured to be in fluid communication with a patient extension set and a flexible movable divider sealing the first fluid chamber from the second fluid chamber. Related apparatus, systems, techniques and articles are also described.
Patent AU-2014241089-B2 (AU)
Title: Capsule suspension formulations of dithiopyr herbicide
Inventor: BREUNINGER JAMES M
IPC: A01N25/28
Filed: 2014-03-10
Granted: 2017-10-26
Abstract: Dithiopyr capsule suspension formulations, possessing a broad range of capsule wall thicknesses and diameters are disclosed. These capsules have decreased volatility and provide enhanced biological activity when compared with commercial dithiopyr in water formulations.
Patent AU-2014255527-B2 (AU)
Title: Methods of cell separation
Inventor: DREW JEFFREY
IPC: C12N5/071
Filed: 2014-04-15
Granted: 2019-12-05
Abstract: The present invention relates to the use of a combination of: (i)a macromolecular erythrocyte sedimentation enhancer, and (ii)dimethyl sulphoxide (DMSO), dimethylglycine (DMG) and/or valine; to recover non-erythrocyte blood cells from a blood cell-containing sample and/or to prime non-erythrocyte blood cells to protect their integrity in subsequent cryopreservation step(s).
Patent AU-2014281049-B2 (AU)
Title: Environmentally aware dialog policies and response generation
Inventor: BOIES DANIEL
IPC: G06F17/27
Filed: 2014-06-05
Granted: 2019-05-02
Abstract: Environmental conditions, along with other information, are used to adjust a response of a conversational dialog system. The environmental conditions may be used at different times within the conversational dialog system. For example, the environmental conditions can be used to adjust the dialog manager's output (e.g., the machine action). The dialog state information that is used by the dialog manager includes environmental conditions for the current turn in the dialog as well as environmental conditions for one or more past turns in the dialog. The environmental conditions can also be used after receiving the machine action to adjust the response that is provided to the user. For example, the environmental conditions may affect the machine action that is determined as well as how the action is provided to the user. The dialog manager and the response generation components in the conversational dialog system each use the available environmental conditions.
Patent AU-2014284834-B2 (AU)
Title: Improved nanoparticle type oligonucleotide structure having high efficiency and method for preparing same
Inventor: PARK HAN OH
IPC: C07H21/00
Filed: 2014-07-04
Granted: 2017-06-08
Abstract: The present invention relates to an oligonucleotide structure and a method for preparing the same and, more particularly, to an oligonucleotide structure in which a polymer compound is linked to an oligonucleotide via a covalent bond to improve in vivo stability of the oligonucleotide and cellular delivery efficiency of the oligonucleotide; and to a method for preparing the same. The oligonucleotide structure is improved into a homogenous material, thereby solving the problem in material verification due to polydispersion characteristics occurring when a hydrophilic material linked to the oligonucleotide is a synthetic polymer; the nucleotide structure is easy to synthesize compared with the existing process; and the size of a double helix oilgo-RNA structure can be accurately adjusted through the control of the number of repetitions of a hydrophilic material block, and thus, the gene expression regulation function of the oligonucleotide does not deteriorate through the synthesis of the optimized oligonucleotide structure, and the oligonucleotide can be delivered into cells at even a relatively low-concentration dosage. Therefore, the oligonucleotide structure of the present invention can be useful as a novel type oligonucleotide delivery system as well as a tool for treating cancers, infectious diseases, and the like.
Patent AU-2014286931-B2 (AU)
Title: Window assembly for a recreational vehicle
Inventor: LEGREW MARK
IPC: B60J1/14
Filed: 2014-07-07
Granted: 2017-08-10
Abstract: A window assembly for recreational vehicles is disclosed which may enable both opening/closing operation of the window and locking/unlocking of the window to be achieved by manual or electromechanical operation of a single hub assembly.
Patent AU-2014347742-B2 (AU)
Title: Controlled retention and removal of biomaterials and microbes
Inventor: ABRAHAM JOSE K
IPC: A61L2/238
Filed: 2014-09-25
Granted: 2017-11-23
Abstract: A system for removing microbes from a surface, where the microbes are retained by a film, or a film that can prevent microbes from attaching on a surface are described, where the film is electrically connected to a voltage source via surface electrodes. The film can include a tunable dielectric material, and the dielectric constant of the dielectric material can be adjusted to alter the attachment of microbes on the surface when the surface is contacted by the dielectric material. The surface to be contacted can include any surface present in households, water treatment facilities, food industry facilities, soil remediation, or medical facilities. Such surfaces can include tables, countertops, wails, cabinets, doors, door handles, door knobs, etc. The system can also be used to treat any devices used in the aforementioned environments, such as food preparation equipment, medical devices, water cooler tower equipment, etc.
Patent AU-2014352826-B2 (AU)
Title: Engineered high-affinity human T cell receptors
Inventor: SMITH SHEENA N
IPC: C07K14/725
Filed: 2014-11-21
Granted: 2019-08-01
Abstract: T cell receptors (TCRs) that have higher affinity for the Survivin antigen are provided. The high affinity TCRs were engineered through the generation of mutational libraries of TCRs in a single-chain format, followed by selection for improved stability and affinity on the surface of yeast (i.e. directed evolution). In embodiments, the engineered TCRs can be used in soluble form for targeted delivery in vivo, or as genes introduced into T cells in an adoptive T cell setting.
Patent AU-2014358766-B2 (AU)
Title: Use of benzimidazole-proline derivatives
Inventor: BOSS CHRISTOPH
IPC: C07D403/14
Filed: 2014-12-03
Granted: 2019-01-17
Abstract: The present invention relates to compounds of the formula (I), wherein Ar
Patent AU-2015201421-B2 (AU)
Title: Active electronically scanned array antenna for hemispherical scan coverage
Inventor: CULKIN DANIEL R
IPC: G01S7/03
Filed: 2015-03-18
Granted: 2016-03-31
Abstract: An antenna architecture for hemispherically-scanning active electronically scanned arrays (AESA) (10). The antenna architecture utilizes variable diameter disks (14) of antenna elements (12) configured in a conical implementation. The antenna elements (12) are oriented such that the element boresight is normal to the surface of the conical structure. Beamforming takes place on each disk (14) first, and then separately in combining the signals from each disk (14), thereby reducing complexity. The antenna (10) optionally utilizes disks (14) of antenna elements (12) of the same diameter to form a cylindrical antenna, which when combined with a conical configuration create enhanced sectors while maintaining a hemispherical coverage capability. Further, use of two conical configurations can produce a fully spherical coverage capability.
Patent AU-2015203221-B2 (AU)
Title: Plate Frame
Inventor: KALAZICH GRAHAM
IPC: B60R13/10
Filed: 2015-06-05
Granted: 2016-12-08
Abstract: Abstract A frame is disclosed for e.g. a license registration plate or a sign, which can then be located on a substrate. The frame may be demountable. The frame may also enable the mounting of the plate to the substrate (which may e.g. be part of a vehicle, or a wall, or a support such as a post or frame, etc). The frame comprises a backing plate. The backing plate is configured so as to define a channel into which the license plate can be located for retention at the backing plate. For example, the backing plate may be configured so as to be extruded. The backing plate, whilst supporting (e.g. whilst cradling and protecting the license plate) can also facilitate mounting of the frame (and hence of the license plate) to a substrate. For example, the backing plate may be adapted to provide a so-called "universal mounting" (e.g. to enable mounting of a license plate to the various mounting points such as may be provided on a host of different vehicle makes and models). In this way, the one frame can mount to many different vehicle makes and models. (N (N (N m (N I-N m u-m (N I-.
Patent AU-2015217045-B2 (AU)
Title: Pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and its cofactor
Inventor: GODFRIN YANN
IPC: A61K9/50
Filed: 2015-02-12
Granted: 2018-03-08
Abstract: The invention relates to a pharmaceutical composition containing a PLP-dependent enzyme and optionally its cofactor, pyridoxal phosphate (PLP), and/or a phosphate or non-phosphate precursor of PLP, its use as a drug, its production method and a therapeutic treatment method related to it. The pharmaceutical composition comprises erythrocytes and a pharmaceutically acceptable vehicle, the erythrocytes encapsulating the PLP-dependent enzyme. The PLP-dependent enzyme may be methioninase, tyrosine phenol-lyase, tyrosine aminotransferase or cystathionine beta-synthase.
Patent AU-2015230778-B2 (AU)
Title: Dosage regimen for therapeutic method
Inventor: GEIMER THOMAS ROBERT
IPC: A61K38/17
Filed: 2015-09-24
Granted: 2017-06-29
Abstract: Disclosed herein is the use of an active agent comprising a peptide derived from atrial natriuretic peptide (ANP) prohormone or a mimetic thereof in the manufacture of a medicament for treating a disease in a subject. The medicament is administered subcutaneously in a multimodal dosage regime comprising at least an initial dosage stage and at least one maintenance dosage stage. The initial dosage stage comprises infusing the active agent at an initial dosage rate for an initial period to achieve a target steady state blood plasma concentration of the active agent or metabolite thereof The maintenance dosage stage(s) comprise(s) adjusting the dosage rate to a maintenance dosage rate for a maintenance period to substantially maintain said target steady state blood plasma concentration of the active agent or metabolite thereof
Patent AU-2015238847-B2 (AU)
Title: High water content oral compositions comprising microcrystalline cellulose and carboxymethylcellulose
Inventor: MELLO SARITA
IPC: A61K8/25
Filed: 2015-10-08
Granted: 2016-12-01
Abstract: The invention provides high water content dentifrice compositions comprising a silica abrasive and a component containing microcrystalline cellulose and carboxymethylcellulose, as well as methods of making and using the same.
Patent AU-2015256641-B2 (AU)
Title: Breathing exerciser
Inventor: LYAPKO MYKOLA
IPC: A63B23/18
Filed: 2015-01-16
Granted: 2020-10-29
Abstract: The invention relates to medical technology, to non-medicinal means for improving physical health and enhancing physical capabilities by means of a breathing system, and specifically relates to devices which are intended for inhaling hypoxic/hypercapnic mixtures having various compositions, and which have an adjustable resistance to inhalation/exhalation. According to a first variant, a breathing exerciser contains a first chamber, which is connected to means for connecting the exerciser to a user's respiratory tract; a second chamber, communicating with the first chamber; a third chamber, communicating with the second chamber; means for adjusting the composition of a breathing mixture; and means for adjusting the resistance to inhalation/exhalation, installed in a channel through which the first chamber and the second chamber communicate. The second chamber communicates with the atmosphere; the third chamber is elastic; means for regulating the composition of a breathing mixture are in the form of adjustable throttling devices installed in the channels through which the second chamber communicates with the third chamber and with the atmosphere; the means for adjusting the resistance to inhalation/exhalation are capable of separately and independently adjusting resistance to inhalation and resistance to exhalation. A second variant is characterized in that a first chamber communicates with a second chamber by means of two parallel channels, in that means for adjusting the resistance to inhalation/exhalation are installed in the parallel channels, and in that a breathing mixture is capable of passing through said channels in mutually opposite directions.
Patent AU-2015264171-B2 (AU)
Title: Carton for articles
Inventor: SPIVEY SR RAYMOND R
IPC: B65D5/468
Filed: 2015-05-21
Granted: 2019-02-07
Abstract: A package comprising a carton and a plurality of articles. The carton can include a plurality of panels that extends at least partially around an interior of the carton. The articles of the plurality of articles can be arranged in a plurality of rows of articles in the interior of the carton. The plurality of rows of articles can include at least a first row and a second row, the second row can be spaced apart from a panel of the plurality of panels by at least the first row, and the first row can include at least one more article than the second row.
Patent AU-2015265399-B2 (AU)
Title: Trigger-type liquid sprayer
Inventor: FUJIWARA KOTARO
IPC: B65D47/34
Filed: 2015-04-27
Granted: 2018-01-04
Abstract: A trigger-type liquid sprayer (1) having, in a flow channel (P) of a sprayer body (11), a valve member (61) for restricting the direction of a flow of liquid in the flow channel (P) from a container (2) toward a nozzle (21) accompanying operation of a pump (31), wherein the valve member (61) is provided with an intake-side check valve (63) for allowing a flow of liquid from the container (2) toward the pump (31) and inhibiting a flow of liquid from the pump (31) toward the container (2), and a discharge-side check valve (64) for allowing a flow of liquid from the pump (31) toward the nozzle (21) and inhibiting a flow of liquid from the nozzle (21) toward the pump (31), and the discharge-side check valve (64) is formed having an umbrella shape elastically deformable in a radial direction and is configured so that an external peripheral end thereof comes in contact with an internal peripheral face of the flow channel, and the force with which the external peripheral end contacts the internal peripheral face of the flow channel (P) is non-uniform in a circumferential direction.
Patent AU-2015315801-B2 (AU)
Title: Multi-level, hardware-enforced domain separation using a separation kernel on a multicore processor with a shared cache
Inventor: WOOLLEY BRANDON
IPC: G06F9/46
Filed: 2015-07-07
Granted: 2020-05-21
Abstract: A separation kernel isolating memory domains within a shared system memory (103, 301, 401) is executed on the cores (202) of a multicore processor (101, 201a-201h) having hardware security enforcement for static virtual address mappings, to implement an efficient embedded multi-level security system (100). Shared caches (208, 209) are either disabled or constrained by the same static virtual address mappings using the hardware security enforcement available, to isolate domains accessible to select cores and reduce security risks from data co-mingling.